- Home
- DVAX vs VRNT Comparison
DVAX vs VRNT Comparison
Compare DVAX & VRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVAX
- VRNT
- Stock Information
- Founded
- DVAX 1996
- VRNT 1994
- Country
- DVAX United States
- VRNT United States
- Employees
- DVAX N/A
- VRNT N/A
- Industry
- DVAX Biotechnology: Pharmaceutical Preparations
- VRNT EDP Services
- Sector
- DVAX Health Care
- VRNT Technology
- Exchange
- DVAX Nasdaq
- VRNT Nasdaq
- Market Cap
- DVAX 1.3B
- VRNT 1.3B
- IPO Year
- DVAX 2004
- VRNT N/A
- Fundamental
- Price
- DVAX $10.26
- VRNT $20.38
- Analyst Decision
- DVAX Buy
- VRNT Buy
- Analyst Count
- DVAX 4
- VRNT 7
- Target Price
- DVAX $26.50
- VRNT $27.33
- AVG Volume (30 Days)
- DVAX 1.8M
- VRNT 2.3M
- Earning Date
- DVAX 08-07-2025
- VRNT 09-03-2025
- Dividend Yield
- DVAX N/A
- VRNT N/A
- EPS Growth
- DVAX N/A
- VRNT 79.53
- EPS
- DVAX N/A
- VRNT 0.84
- Revenue
- DVAX $316,268,000.00
- VRNT $896,006,000.00
- Revenue This Year
- DVAX $23.23
- VRNT $7.74
- Revenue Next Year
- DVAX $16.57
- VRNT $5.56
- P/E Ratio
- DVAX N/A
- VRNT $24.15
- Revenue Growth
- DVAX 26.66
- VRNT N/A
- 52 Week Low
- DVAX $9.22
- VRNT $14.15
- 52 Week High
- DVAX $14.63
- VRNT $34.80
- Technical
- Relative Strength Index (RSI)
- DVAX 42.08
- VRNT 51.34
- Support Level
- DVAX $10.27
- VRNT $18.40
- Resistance Level
- DVAX $11.45
- VRNT $20.56
- Average True Range (ATR)
- DVAX 0.45
- VRNT 0.74
- MACD
- DVAX -0.06
- VRNT 0.02
- Stochastic Oscillator
- DVAX 18.18
- VRNT 65.56
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
About VRNT Verint Systems Inc.
Verint Systems Inc with its subsidiaries, helps brands provide Boundless customer experience (CX) automation. AI offers a solution, and that's where Verint comes in. It empowers brands with groundbreaking AI via a next-gen open platform. Its Verint Open Platform helps organizations increase CX automation to achieve their strategic objectives and realize ROI. Geographically, it derives a majority of its revenue from the United States.